Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 899.90
-2.30 (-0.25%)
At close: Dec 5, 2025
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 16,571 employees as of March 31, 2025. The number of employees increased by 1,713 or 11.53% compared to the previous year.
Employees
16,571
Change (1Y)
1,713
Growth (1Y)
11.53%
Revenue / Employee
4.27M INR
Profits / Employee
382.83K INR
Market Cap
176.87B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16,571 | 1,713 | 11.53% |
| Mar 31, 2024 | 14,858 | 265 | 1.82% |
| Mar 31, 2023 | 14,593 | 2,377 | 19.46% |
| Mar 31, 2022 | 12,216 | 56 | 0.46% |
| Mar 31, 2021 | 12,160 | 584 | 5.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Alembic Pharmaceuticals News
- 19 days ago - Alembic Pharma shares rise over 2% after USFDA nod for Diltiazem Hydrochloride Tablets - Business Upturn
- 21 days ago - Alembic Pharma gets USFDA final nod for Diltiazem Hydrochloride Tablets - Business Upturn
- 23 days ago - Alembic Pharma secures final USFDA approval for Dexlansoprazole DR capsules - Business Upturn
- 4 weeks ago - Alembic Pharmaceuticals receives USFDA final approval for Dasatinib Tablets across six strengths - Business Upturn
- 4 weeks ago - Q2 2026 Alembic Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Alembic Pharma shares rally sharply over 6% as Q2 net profit jumps 21% YoY to Rs 185 crore, revenue up 16% - Business Upturn
- 5 weeks ago - Alembic Pharmaceuticals gets USFDA final approval for Ticagrelor Tablets 60 mg; targets $236 million market - Business Upturn
- 3 months ago - Alembic Pharma receives USFDA final approval for Phytonadione Injectable Emulsion USP - Business Upturn